These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 15306843)
1. In vivo transfection of a cis element 'decoy' against signal transducers and activators of the transcription 6 (STAT6) binding site ameliorates the response of contact hypersensitivity. Sumi K; Yokozeki H; Wu MH; Satoh T; Kaneda Y; Takeda K; Akira S; Nishioka K Gene Ther; 2004 Dec; 11(24):1763-71. PubMed ID: 15306843 [TBL] [Abstract][Full Text] [Related]
2. In vivo transfection of a cis element 'decoy' against signal transducers and activators of transcription 6 (STAT6)-binding site ameliorates IgE-mediated late-phase reaction in an atopic dermatitis mouse model. Yokozeki H; Wu MH; Sumi K; Awad S; Satoh T; Katayama I; Takeda K; Akira S; Kaneda Y; Nishioka K Gene Ther; 2004 Dec; 11(24):1753-62. PubMed ID: 15306842 [TBL] [Abstract][Full Text] [Related]
3. Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse. Takeshita K; Yamasaki T; Akira S; Gantner F; Bacon KB Int Immunol; 2004 May; 16(5):685-95. PubMed ID: 15096484 [TBL] [Abstract][Full Text] [Related]
4. Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model. Kawamura I; Morishita R; Tomita N; Lacey E; Aketa M; Tsujimoto S; Manda T; Tomoi M; Kida I; Higaki J; Kaneda Y; Shimomura K; Ogihara T Gene Ther; 1999 Jan; 6(1):91-7. PubMed ID: 10341880 [TBL] [Abstract][Full Text] [Related]
5. Signal transducer and activator of transcription 6 is essential in the induction of contact hypersensitivity. Yokozeki H; Ghoreishi M; Takagawa S; Takayama K; Satoh T; Katayama I; Takeda K; Akira S; Nishioka K J Exp Med; 2000 Mar; 191(6):995-1004. PubMed ID: 10727461 [TBL] [Abstract][Full Text] [Related]
7. Molecular strategy using cis-element 'decoy' of E2F binding site inhibits neointimal formation in porcine balloon-injured coronary artery model. Nakamura T; Morishita R; Asai T; Tsuboniwa N; Aoki M; Sakonjo H; Yamasaki K; Hashiya N; Kaneda Y; Ogihara T Gene Ther; 2002 Apr; 9(8):488-94. PubMed ID: 11948373 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element 'decoy' of nuclear factor-kappaB binding site as a novel molecular strategy. Yoshimura S; Morishita R; Hayashi K; Yamamoto K; Nakagami H; Kaneda Y; Sakai N; Ogihara T Gene Ther; 2001 Nov; 8(21):1635-42. PubMed ID: 11895002 [TBL] [Abstract][Full Text] [Related]
9. Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice. Kawamura I; Morishita R; Tsujimoto S; Manda T; Tomoi M; Tomita N; Goto T; Ogihara T; Kaneda Y Gene Ther; 2001 Jun; 8(12):905-12. PubMed ID: 11426330 [TBL] [Abstract][Full Text] [Related]
10. Th2 cytokines, IgE and mast cells play a crucial role in the induction of para-phenylenediamine-induced contact hypersensitivity in mice. Yokozeki H; Wu MH; Sumi K; Igawa K; Miyazaki Y; Katayama I; Takeda K; Akira S; Nishioka K Clin Exp Immunol; 2003 Jun; 132(3):385-92. PubMed ID: 12780683 [TBL] [Abstract][Full Text] [Related]
11. A novel strategy for myocardial protection using in vivo transfection of cis element 'decoy' against NFkappaB binding site: evidence for a role of NFkappaB in ischemia-reperfusion injury. Sawa Y; Morishita R; Suzuki K; Kagisaki K; Kaneda Y; Maeda K; Kadoba K; Matsuda H Circulation; 1997 Nov; 96(9 Suppl):II-280-4; discussion II-285. PubMed ID: 9386111 [TBL] [Abstract][Full Text] [Related]
12. A nucleic acid-based medication for allergic skin diseases. Yokozeki H J Dermatol Sci; 2014 Aug; 75(2):75-81. PubMed ID: 24726501 [TBL] [Abstract][Full Text] [Related]
13. Attenuation of murine antigen-induced arthritis by treatment with a decoy oligodeoxynucleotide inhibiting signal transducer and activator of transcription-1 (STAT-1). Hückel M; Schurigt U; Wagner AH; Stöckigt R; Petrow PK; Thoss K; Gajda M; Henzgen S; Hecker M; Bräuer R Arthritis Res Ther; 2006; 8(1):R17. PubMed ID: 16507120 [TBL] [Abstract][Full Text] [Related]
15. Prevention and regression of atopic dermatitis by ointment containing NF-kB decoy oligodeoxynucleotides in NC/Nga atopic mouse model. Nakamura H; Aoki M; Tamai K; Oishi M; Ogihara T; Kaneda Y; Morishita R Gene Ther; 2002 Sep; 9(18):1221-9. PubMed ID: 12215889 [TBL] [Abstract][Full Text] [Related]
16. CRTH2-dependent, STAT6-independent induction of cedar pollen dermatitis. Oiwa M; Satoh T; Watanabe M; Niwa H; Hirai H; Nakamura M; Yokozeki H Clin Exp Allergy; 2008 Aug; 38(8):1357-66. PubMed ID: 18477017 [TBL] [Abstract][Full Text] [Related]
17. Skin application of ketoprofen systemically suppresses contact hypersensitivity by inducing CD4(+) CD25(+) regulatory T cells. Atarashi K; Mori T; Yoshiki R; Kabashima K; Kuma H; Tokura Y J Dermatol Sci; 2009 Mar; 53(3):216-21. PubMed ID: 19157794 [TBL] [Abstract][Full Text] [Related]
18. B cells are not required for T cell priming in low zone tolerance to contact allergens and contact hypersensitivity. Seidel-Guyenot W; Alt R; Perschon S; Knop J; Steinbrink K Eur J Immunol; 2004 Nov; 34(11):3082-90. PubMed ID: 15376190 [TBL] [Abstract][Full Text] [Related]